60 filings
Page 2 of 3
8-K
v7f3 c2ayy
21 Nov 23
SeaStar Medical Reports Third Quarter 2023 Financial Results and Provides a Business Update
6:04pm
8-K
yzsdmx
30 Oct 23
FDA Issues Approvable Letter for SeaStar Medical’s Selective Cytopheretic Device for Pediatric Patients
8:15am
8-K
7i3ueioxpsjyji
3 Oct 23
Company to finalize labeling with FDA Approvable Letter expected within a month
4:07pm
8-K
2io0pc7dv489he
26 Sep 23
Other Events
9:33am
8-K
5gv9u v7rt8
20 Sep 23
Amendments to Articles of Incorporation or Bylaws
5:16pm
8-K
0zy3 r6mgt6m
8 Sep 23
Submission of Matters to a Vote of Security Holders
2:30pm
8-K
kv2 q5e4ampz
30 Aug 23
Entry into a Material Definitive Agreement
4:35pm
8-K
4agyux
24 Aug 23
Regulation FD Disclosure
5:15pm
8-K
ke9i9n7twgrc
14 Aug 23
SeaStar Medical Reports Second Quarter 2023 Financial Results and Provides a Business Update
6:46pm
8-K
juq6ribi
7 Aug 23
Entry into a Material Definitive Agreement
8:23pm
8-K
rgzvb3
2 Aug 23
Changes in Registrant's Certifying Accountant
4:19pm
8-K
gao1 uod5i8d
30 Jun 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:06pm
8-K
kjsxp83
16 Jun 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:01pm
8-K
oldo eqajk
9 Jun 23
Entry into a Material Definitive Agreement
4:01pm
8-K
y4wpmgz4 0s2f
16 May 23
SeaStar Medical Reports First Quarter 2023 Financial Results and Provides a Business Update
4:06pm
8-K
szos l311q3az99ht
9 May 23
SeaStar Medical Provides Regulatory Update Related to its HDE Application for Pediatric Selective Cytopheretic Device
5:02pm
8-K
nubq8n1vck 9a4eqgq05
30 Mar 23
SeaStar Medical Reports 2022 Financial Results and Provides a Business Update
9:58pm
8-K
mf47bcbdf0
16 Mar 23
SeaStar Medical Holding Corporation Closes Initial $3.3 Million Tranche of $9.8 Million Private Placement
8:30am
8-K
d0xvebwk10
15 Feb 23
Regulation FD Disclosure
12:00am
8-K
qhh7 83c7qwdce8sgv
9 Feb 23
SeaStar Medical Receives FDA Approval to Begin Study with Selective Cytopheretic Device to
4:06pm